click
Contact

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Facebook
LinkedIn
Fill out the form below to download this content.
Leveraging-a-Humanized-SLE-Mouse-Model-to-Evaluate-Next-Generation-Immune-Cell-Targeted-Therapeutics

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics

Name(Required)
By clicking submit you consent to receive email communications about products and services of Medicilon and are in accordance with our Privacy Policy. You may opt out at any time.
Contact

Search Medicilon

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Read more
Preclinical CRO

World’s First Phase III Positive B7-H3 ADC: Medicilon Congratulates MediLink Therapeutics on NDA Acceptance of Icontamrotamab

Read more
Preclinical CRO

Medicilon Webinar | IND-enabling Toxicity Studies, CTD Documentation and Translational Cardiac Risk Assessment

Read more

Contact Medicilon

Name(Required)
Address(Required)